Market
BSE Prices delayed by 5 minutes... << Prices as on Apr 19, 2024 >>  ABB India  6291.2 [ -1.19% ] ACC  2406.8 [ -0.22% ] Ambuja Cements  609.45 [ -1.11% ] Asian Paints Ltd.  2808.45 [ -0.22% ] Axis Bank Ltd.  1029.5 [ 0.52% ] Bajaj Auto  8795.45 [ -2.47% ] Bank of Baroda  256.95 [ -0.85% ] Bharti Airtel  1288.9 [ 1.71% ] Bharat Heavy Ele  254.45 [ 0.51% ] Bharat Petroleum  585.9 [ -0.65% ] Britannia Ind.  4668.1 [ -0.57% ] Cipla  1345.35 [ -0.17% ] Coal India  435.25 [ -0.80% ] Colgate Palm.  2650.65 [ -0.58% ] Dabur India  504.35 [ 0.05% ] DLF Ltd.  855.85 [ -0.02% ] Dr. Reddy's Labs  5942.65 [ -0.28% ] GAIL (India)  202 [ -0.76% ] Grasim Inds.  2274.35 [ 2.10% ] HCL Technologies  1447.9 [ -1.35% ] HDFC  2729.95 [ -0.62% ] HDFC Bank  1531.3 [ 2.46% ] Hero MotoCorp  4215.15 [ -0.88% ] Hindustan Unilever L  2232.25 [ 0.78% ] Hindalco Indus.  614.5 [ 0.28% ] ICICI Bank  1066.4 [ 1.04% ] IDFC L  122.75 [ 0.61% ] Indian Hotels Co  596.65 [ 0.50% ] IndusInd Bank  1483.15 [ 0.62% ] Infosys L  1411.6 [ -0.63% ] ITC Ltd.  424.8 [ 1.40% ] Jindal St & Pwr  927.45 [ 2.44% ] Kotak Mahindra Bank  1793.2 [ 0.38% ] L&T  3519.25 [ -0.89% ] Lupin Ltd.  1547.05 [ -2.92% ] Mahi. & Mahi  2082.9 [ 2.90% ] Maruti Suzuki India  12710.65 [ 2.54% ] MTNL  34.95 [ -2.21% ] Nestle India  2437.1 [ -1.04% ] NIIT Ltd.  105.35 [ -0.80% ] NMDC Ltd.  235.65 [ 0.26% ] NTPC  350.9 [ -0.14% ] ONGC  275.15 [ 0.31% ] Punj. NationlBak  128.25 [ -1.00% ] Power Grid Corpo  281.7 [ 0.54% ] Reliance Inds.  2941.6 [ 0.46% ] SBI  750.8 [ 0.81% ] Vedanta  385.85 [ -0.78% ] Shipping Corpn.  209.25 [ -0.69% ] Sun Pharma.  1522.55 [ 0.36% ] Tata Chemicals  1103.35 [ -0.21% ] Tata Consumer Produc  1137.5 [ 0.29% ] Tata Motors Ltd.  963.2 [ -0.84% ] Tata Steel  162.1 [ 1.31% ] Tata Power Co.  428 [ -0.44% ] Tata Consultancy  3827.45 [ -0.93% ] Tech Mahindra  1193.75 [ 1.18% ] UltraTech Cement  9367.4 [ -0.21% ] United Spirits  1122.7 [ -2.46% ] Wipro  452.85 [ 1.92% ] Zee Entertainment En  142.85 [ -1.45% ] 
Bacil Pharma Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 11.10 Cr. P/BV 24.04 Book Value (Rs.) 0.78
52 Week High/Low (Rs.) 19/5 FV/ML 10/1 P/E(X) 0.00
Bookclosure 16/09/2023 EPS (Rs.) 0.00 Div Yield (%) 0.00
Year End :2014-03 
We have audited the accompanying financial statements of BACIL PHARMA LIMITED ("the Company"), which comprise the Balance Sheet as at 31st March, 2014, and the Statement of Profit and Loss and Cash Flow Statement for the year then ended, and a summary of significant accounting policies and other explanatory information.

Management's Responsibility for the Financial Statements

Management is responsible for the preparation of these financial statements that give a true and fair view of the financial position, financial performance and cash flows of the Company in accordance with the Accounting Standards referred to in Sub-Section (3C) of Section 211 of the Companies Act, 1956 ("the Act"') read with the General Circular 15/2013 dated 13th September 2013 of the Ministry of Corporate Affairs in respect of Section 133 of the Companies Act, 2013. This responsibility includes the design, implementation and maintenance of internal control relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

Auditor's Responsibility

Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with the Standards on Auditing issued by the Institute of Chartered Accountants of India. Those Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the Company's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of the accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion and to the best of our information and according to the explanations given to us, the financial statements give the information required by the Act in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India:

(a) in the case of the Balance Sheet, of the state of affairs of the Company as at 31st March, 2014;

(b) in the case of the Statement of Profit and Loss, of the loss for the year ended on that date; and

(c) in the case of the Cash Flow Statement, of the cash flows for the year ended on that date.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor's Report) Order, 2003 ("the Order") issued by the Central Government of India in terms of sub-section (4A) of Section 227 of the Act, we give in the Annexure a statement on the matters specified in paragraphs 4 and 5 of the Order.

2. As required by Section 227(3) of the Act, we report that:

a. we have obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purpose of our audit;

b. in our opinion, proper books of account as required by law have been kept by the Company so far as appears from our examination of those books;

c. the Balance Sheet, Statement of Profit and Loss, and Cash Flow Statement dealt with by this Report are in agreement with the books of account;

d. in our opinion, the Balance Sheet, Statement of Profit and Loss, and Cash Flow Statement comply with the Accounting Standards referred to in sub-section (3C) of Section 211 of the Companies Act, 1956 read with the General Circular 15/2013 dated 13th September 2013 of the Ministry of Corporate Affairs in respect of Section 133 of the Companies Act, 2013;

e. on the basis of written representations received from the directors as on 31st March, 2014, and taken on record by the Board of Directors, none of the directors is disqualified as on 31st march, 2014, from being appointed as a director in terms of clause (g) of sub-section (1) of Section 274 of the Companies Act, 1956.

ANNEXURE TO THE INDEPENDENT AUDITORS' REPORT

(Referred to in paragraph 1 of our report of even date to the members of BACIL PHARMA LIMITED on the financial statements for the year ended on 31st March, 2014.)

1) The provisions of clauses ii, x, xi, xii, xiii, xiv, xv, xvi, xviii and xix of paragraph 4 and 5 of the Companies (Auditors' Report) Order, 2003 are not applicable for the current year.

2) In respect of its fixed assets:

(a) The Company has maintained proper records showing full particulars, including quantitative details and situation of fixed assets.

(b) As informed to us, fixed assets of the company were physically verified during the year by the Management in accordance with a program of verification, which in our opinion provides for physical verification of all the fixed assets at reasonable intervals. According to the information and explanations given to us no material discrepancies were noticed on such verification.

3) During the year the Company has neither granted nor taken any loan, secured or unsecured to/from the Companies, firms or other parties covered in the Register maintained u/s 301 of the Companies Act, 1956.

As explained to us, the Company has entered into all the particulars of contracts or arrangements referred to in section 301 of the Act.

4) In our opinion and according to the information and explanations given to us, the company has adequate internal control procedures commensurate with the size of the company and nature of its business with regard to purchase and sale of plant and machinery, equipment and other assets.

5) According to the information and explanations provided by the management, there have been no transactions that need to be entered into the register maintained under Section 301 of the Companies Act, 1956.

6) The company has not accepted any deposits from the public. Accordingly provisions of section 58A and 58AA of Companies Act, 1956 are not applicable to the company.

7) In our opinion the company has an internal audit system commensurate with the size and nature of its Business.

8) The Central Government has not prescribed the maintenance of Cost Records under Section 209(1) of the Companies Act, 1956 for any of the products of the Company.

9) a) As informed to us Provident Fund and Employee State Insurance Act is not applicable to the Company.

b) According to the information and explanations given to us, there was no undisputed amounts payable in respect of Income-Tax, Wealth-tax, Sales-tax, Custom Duty and Excise Duty, which have remained outstanding as at the date of Balance Sheet for the period of more than six months from the date they became payable.

10) According to the cash flow statement and other records examined by us and the information and explanations given to us, on an overall basis, funds raised on short term basis have, prima facie, not been used during the year for long term investments (fixed assets, etc.) and vice versa, other than temporary deployment pending application.

11) The Company has not raised any money through a public issue during the year under review.

12) To the best of our knowledge and belief and according to the information and explanations given to us, no fraud on or by the company was noticed or reported during the year.

Place:    Mumbai                                 For A. W. KETKAR & CO.
Dated:    May 30, 2014                            Chartered Accountants
                                              Registration No.: 105006W

Address:  4, "SOUKHYA", Opp. B.M.C. Hospital               A. W. KETKAR
          V. N. Purav Marg                                   Proprietor
          Chunabhatti, Mumbai 400 022            Membership No.: 012287

KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
 
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732
KK Comtrade Pvt Ltd. : Member - MCXINDIA (Commodity Segment) , SEBI NO: INZ000034837
Mumbai Office: 52, Jolly Maker Chamber 2, Nariman Point, Mumbai - 400021, Tel: 022-45106700, Toll Free Number: 1800-103-6700

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by